This study thus aims to explore the expression and significance of POLR2J4 in HBV-induced HCC patients by analyzing clinical samples and data, with the goal of identifying a potential biomarker for HBV-induced HCC. Here, POLR2J4 is linked to hepatocellular carcinoma.